CD47 and breast carcinoma: CD47, here revealed to be up-regulated in uterine corpus endometrial carcinoma (Table 1), and to be associated to an unfavorable prognosis when showing this expression trend (Figure 1), has been reported to be up-regulated also in other cancers, such as acute myeloid leukemia, breast cancer, melanoma and non-Hodgkin lymphoma [92,93,94,95].